EASTON BIOPHARMACEUTICALS
68851346.381.74% ( -0.82 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: EASTON BIOPHARMACEUTICALS(688513) the Revenue is 326.26 M (+6.75%);the EBIT is 40.62 M (-28.72%);the EPS is 0.29 (-14.71%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.33B6.75%
----
----
EBIT
0.04B28.72%
----
----
EPS
0.2914.71%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf